Long-term impact of secondary preventive treatments in patients with stable angina

Zoltán Vokó, Sophie De Brouwer, Jacobus Lubsen, Nicolas Danchin, Jan Erik Otterstad, Peter H.J.M. Dunselman, Bridget Anne Kirwan

Research output: Contribution to journalArticle

6 Citations (Scopus)


We assessed the independent effects of beta blockers, calcium antagonists, lipid-lowering drugs, angiotensin converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), anti-platelet drugs, vitamin K antagonists, percutaneous coronary intervention (PCI) and coronary artery by-pass grafting (CABG) on mortality and on the composite endpoint of death, myocardial infarction, stroke or heart failure in patients with stable angina pectoris. We estimated the effects of the interventions used at baseline by multivariate Cox regression and during follow-up by G-estimation in 7,665 patients followed for a mean of 5 years in the ACTION trial. Adjusted hazard ratios (95% confidence intervals) comparing all cause mortality among users during follow-up to non-users were 1.01 (0.91, 1.09) for beta blockade, 0.82 (0.75, 0.89) for ACEIs or ARBs, 0.93 (0.87, 0.98) for calcium antagonists, 0.54 (0.49, 0.62) for lipid-lowering drugs, 0.49 (0.42, 0.53) for anti-platelet drugs, 0.74 (0.69, 0.78) for PCI, and 0.91 (0.82, 0.98) for CABG. Effects on the composite endpoint were less marked. This observational study confirms that ACEIs or ARBs, lipid-lowering and anti-platelet drugs as used in the everyday management of stable angina have independent secondary preventive effects. Calcium antagonists, PCI and CABG also appear to improve outcome.

Original languageEnglish
Pages (from-to)375-383
Number of pages9
JournalEuropean Journal of Epidemiology
Issue number5
Publication statusPublished - May 1 2011


  • Angina pectoris
  • Cardiovascular agents
  • Coronary artery bypass
  • Coronary disease
  • G-estimation
  • Percutaneous coronary intervention
  • Secondary prevention

ASJC Scopus subject areas

  • Epidemiology

Fingerprint Dive into the research topics of 'Long-term impact of secondary preventive treatments in patients with stable angina'. Together they form a unique fingerprint.

  • Cite this

    Vokó, Z., De Brouwer, S., Lubsen, J., Danchin, N., Otterstad, J. E., Dunselman, P. H. J. M., & Kirwan, B. A. (2011). Long-term impact of secondary preventive treatments in patients with stable angina. European Journal of Epidemiology, 26(5), 375-383. https://doi.org/10.1007/s10654-011-9558-5